Susquehanna International Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205K Buy
51,900
+7,200
+16% +$36.3K ﹤0.01% 11658
2025
Q4
$303K Sell
44,700
-24,900
-36% -$175K ﹤0.01% 9928
2025
Q3
$486K Buy
69,600
+49,100
+240% +$341K ﹤0.01% 9021
2025
Q2
$125K Sell
20,500
-6,600
-24% -$43.9K ﹤0.01% 11646
2025
Q1
$206K Buy
27,100
+10,600
+64% +$88.6K ﹤0.01% 10875
2024
Q4
$159K Buy
+16,500
New +$129K ﹤0.01% 10970
2024
Q3
Sell
-51,700
Closed -$358K 12600
2024
Q2
$358K Buy
51,700
+12,800
+33% +$90K ﹤0.01% 9065
2024
Q1
$300K Buy
38,900
+20,600
+113% +$166K ﹤0.01% 9692
2023
Q4
$160K Sell
18,300
-4,600
-20% -$33.7K ﹤0.01% 10906
2023
Q3
$167K Sell
22,900
-14,000
-38% -$104K ﹤0.01% 10439
2023
Q2
$244K Buy
36,900
+24,800
+205% +$126K ﹤0.01% 9856
2023
Q1
$41.3K Sell
12,100
-24,100
-67% -$93.3K ﹤0.01% 11770
2022
Q4
$101K Buy
36,200
+10,000
+38% +$29.9K ﹤0.01% 10955
2022
Q3
$75K Sell
26,200
-21,800
-45% -$77.5K ﹤0.01% 11934
2022
Q2
$167K Buy
48,000
+15,400
+47% +$60.3K ﹤0.01% 10891
2022
Q1
$154K Sell
32,600
-47,100
-59% -$230K ﹤0.01% 11537
2021
Q4
$481K Sell
79,700
-59,900
-43% -$416K ﹤0.01% 9316
2021
Q3
$846K Sell
139,600
-44,400
-24% -$500K ﹤0.01% 7995
2021
Q2
$2.3M Buy
184,000
+98,900
+116% +$1.07M ﹤0.01% 5603
2021
Q1
$877K Buy
85,100
+20,100
+31% +$194K ﹤0.01% 8075
2020
Q4
$590K Buy
+65,000
New +$468K ﹤0.01% 7922
2018
Q4
Sell
-1,117,600
Closed -$6.91M 9549
2018
Q3
$6.91M Buy
1,117,600
+667,100
+148% +$3.02M ﹤0.01% 2305
2018
Q2
$2.88M Buy
450,500
+11,100
+3% +$79K ﹤0.01% 3443
2018
Q1
$3.06M Buy
439,400
+99,500
+29% +$1.16M ﹤0.01% 3224
2017
Q4
$4.29M Sell
339,900
-277,300
-45% -$3.38M ﹤0.01% 2720
2017
Q3
$7.33M Buy
617,200
+550,600
+827% +$8.17M ﹤0.01% 2075
2017
Q2
$997K Buy
66,600
+22,800
+52% +$304K ﹤0.01% 5266
2017
Q1
$417K Buy
43,800
+26,200
+149% +$221K ﹤0.01% 6813
2016
Q4
$156K Sell
17,600
-52,200
-75% -$469K ﹤0.01% 8823
2016
Q3
$599K Sell
69,800
-98,600
-59% -$781K ﹤0.01% 5723
2016
Q2
$1.34M Sell
168,400
-67,100
-28% -$522K ﹤0.01% 4270
2016
Q1
$2.06M Buy
235,500
+12,400
+6% +$103K ﹤0.01% 3712
2015
Q4
$2.09M Buy
223,100
+100,100
+81% +$867K ﹤0.01% 3947
2015
Q3
$1.19M Sell
123,000
-80,500
-40% -$850K ﹤0.01% 5342
2015
Q2
$2.36M Buy
203,500
+34,400
+20% +$354K ﹤0.01% 4360
2015
Q1
$1.76M Buy
169,100
+136,500
+419% +$1.28M ﹤0.01% 4566
2014
Q4
$376K Sell
32,600
-8,000
-20% -$79K ﹤0.01% 7761
2014
Q3
$289K Sell
40,600
-500
-1% -$3.48K ﹤0.01% 8085
2014
Q2
$291K Sell
41,100
-14,500
-26% -$84.9K ﹤0.01% 8431
2014
Q1
$341K Buy
+55,600
New +$409K ﹤0.01% 7399
2013
Q4
Sell
-20,800
Closed -$87K 9172
2013
Q3
$87K Buy
+20,800
New +$115K ﹤0.01% 8121

Other funds holding MDXG

Susquehanna International Group's MDXG Position: Q1 2026 in Review

Susquehanna International Group increased its MiMedx Group (MDXG) stake by 169% in Q1 2026, buying an estimated $291K and bringing the position to 92,015 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #10433.

Susquehanna International Group first reported a position in MDXG in Q2 2013 and has held it in 35 quarters since. The position peaked at $6M in Q1 2021. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Susquehanna International Group held 92,015 shares of MiMedx Group worth $363K as of Q1 2026.
  • Susquehanna International Group bought 57,821 MiMedx Group shares in Q1 2026, an estimated $291K.
  • MiMedx Group made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10433 holding.
  • Susquehanna International Group first reported a position in MiMedx Group in Q2 2013 and has held it in 35 quarters since.
  • Susquehanna International Group's MiMedx Group position peaked at $6M in Q1 2021.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.